Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to PSYCHEDELICS

The New England Journal of Medicine

Perspective: How Should the FDA Evaluate Psychedelic Medicine?

Psychiatry November 14th 2023

Psych Congress Network

Psychedelics Show Potential to Improve SUD Treatment Outcomes

Psychiatry November 7th 2023

Psych Congress Network

Studies Illustrate Potential of MDMA-, Psilocybin-Assisted Therapies

Psychiatry November 7th 2023

Psych Congress Network

Second Phase 3 Study of MDMA-Assisted Therapy for PTSD Confirms Findings

Neurology October 3rd 2023

Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy

Psychiatry August 30th 2023

Psych Congress Network

Field Leaders Publish Professional Practice Guidelines for Psychedelic-Assisted Therapy

Psychiatry August 15th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form